Target intelligence / Profile preview

Tubulin tyrosine ligase-like protein 7 (TTLL7)

Target
TTLL7
Molecular classification
Enzyme, Tubulin tyrosine ligase-like family, Polyglutamylase
01

Overview

TTLL7, or Tubulin tyrosine ligase-like protein 7, is a member of the tubulin tyrosine ligase-like (TTLL) enzyme family that catalyzes polyglutamylation, a post-translational modification where glutamate chains are added to specific residues on the C-terminal tail of beta-tubulin. TTLL7 is ATP-dependent and capable of both initiating and elongating polyglutamate chains, showing preferential activity on beta-tubulin over alpha-tubulin. This modification regulates microtubule dynamics, affecting neuronal development and cellular transport by modulating microtubule-associated protein interactions. TTLL7 is highly expressed in the nervous system, and its activity is essential for proper growth of MAP2-positive neurites. Mutations or dysregulation of TTLL7 and related TTLL family proteins have been linked to several neurodegenerative diseases, indicating potential disease relevance as a therapeutic target

Other names
Tubulin polyglutamylase TTLL7FLJ23033Testis development protein NYD-SP30Tubulin--tyrosine ligase-like protein 7Tubulin tyrosine ligase-like family member 7
02

Mechanism of action

No specific mechanism for therapeutic inhibition or activation described; mechanistically, polyglutamylases catalyze the ATP-dependent addition of glutamate chains to tubulin

03

Biological functions

Polyglutamylation of tubulinRegulation of microtubule dynamicsNeuronal development, particularly growth of MAP2-positive neuritesModulation of cellular transport along microtubulesInvolvement in post-translational protein modification
04

Disease associations

Neurodegenerative disease (e.g., retinal dystrophy, Joubert syndrome)Cone-Rod Dystrophy 2Fundus Dystrophy

Beyond the preview

Go deeper on Tubulin tyrosine ligase-like protein 7 (TTLL7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin tyrosine ligase-like protein 7 (TTLL7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call